Approval · Notice of Compliance 19970 · 2017
AURO-DUTASTERIDE: Notice of Compliance 19970
Issued October 27, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19970
- Date
- October 27, 2017
- Company
- Auro Pharma Inc.Woodbridge, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- AVODART (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AURO-DUTASTERIDE | 02469308 | Marketed |
Medicinal ingredients
- DUTASTERIDE 0.5 MG per CAP